
Sunshine Biopharma Inc
NASDAQ:SBFM

Intrinsic Value
The intrinsic value of one
SBFM
stock under the Base Case scenario is
27.98
USD.
Compared to the current market price of 1.47 USD,
Sunshine Biopharma Inc
is
Undervalued by 95%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Sunshine Biopharma Inc
Balance Sheet Decomposition
Sunshine Biopharma Inc
Current Assets | 27.9m |
Cash & Short-Term Investments | 10.3m |
Receivables | 3.6m |
Other Current Assets | 14m |
Non-Current Assets | 4.1m |
PP&E | 1.5m |
Intangibles | 2.5m |
Other Non-Current Assets | 92.3k |
Free Cash Flow Analysis
Sunshine Biopharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Sunshine Biopharma Inc
Revenue
|
36.3m
USD
|
Cost of Revenue
|
-24.2m
USD
|
Gross Profit
|
12.1m
USD
|
Operating Expenses
|
-17.5m
USD
|
Operating Income
|
-5.4m
USD
|
Other Expenses
|
-873.9k
USD
|
Net Income
|
-6.3m
USD
|
SBFM Profitability Score
Profitability Due Diligence
Sunshine Biopharma Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Score
Sunshine Biopharma Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
SBFM Solvency Score
Solvency Due Diligence
Sunshine Biopharma Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Sunshine Biopharma Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SBFM Price Targets Summary
Sunshine Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
SBFM
is 7.14 USD
with a low forecast of 7.07 USD and a high forecast of 7.35 USD.
Dividends
Current shareholder yield for SBFM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?